These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7501355)

  • 1. Nuchal translucency measurement in normal fetuses.
    Pajkrt E; Bilardo CM; Van Lith JM; Mol BW; Bleker OP
    Obstet Gynecol; 1995 Dec; 86(6):994-7. PubMed ID: 7501355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weekly nuchal translucency measurements in normal fetuses.
    Pajkrt E; de Graaf IM; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Obstet Gynecol; 1998 Feb; 91(2):208-11. PubMed ID: 9469277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
    Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
    BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy.
    Brizot ML; Snijders RJ; Bersinger NA; Kuhn P; Nicolaides KH
    Obstet Gynecol; 1994 Dec; 84(6):918-22. PubMed ID: 7526305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
    Papageorghiou AT; Avgidou K; Spencer K; Nix B; Nicolaides KH
    Am J Obstet Gynecol; 2006 Feb; 194(2):397-401. PubMed ID: 16458636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of fetuses with enlarged nuchal translucency and normal karyotype.
    Bilardo CM; Pajkrt E; de Graaf I; Mol BW; Bleker OP
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):401-6. PubMed ID: 9674085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuchal translucency measurements: frequency distribution and changes with gestation in a general population.
    Braithwaite JM; Morris RW; Economides DL
    Br J Obstet Gynaecol; 1996 Dec; 103(12):1201-4. PubMed ID: 8968236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of nuchal cord on nuchal translucency measurement at 10-14 weeks.
    Schaefer M; Laurichesse-Delmas H; Ville Y
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):271-3. PubMed ID: 9618851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disappearance of enlarged nuchal translucency before 14 weeks' gestation: relationship with chromosomal abnormalities and pregnancy outcome.
    Müller MA; Pajkrt E; Bleker OP; Bonsel GJ; Bilardo CM
    Ultrasound Obstet Gynecol; 2004 Aug; 24(2):169-74. PubMed ID: 15287055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of fetal position on nuchal translucency thickness.
    de Graaf IM; Müller MA; van Zuylen-Vié AA; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 2000 Jun; 15(6):520-2. PubMed ID: 11005121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal nuchal translucency thickness at 10-14 weeks' gestation and congenital diaphragmatic hernia.
    Sebire NJ; Snijders RJ; Davenport M; Greenough A; Nicolaides KH
    Obstet Gynecol; 1997 Dec; 90(6):943-6. PubMed ID: 9397108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
    Lam YH; Tang MH; Lee CP; Tse HY
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
    McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
    Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
    Souka AP; Snijders RJ; Novakov A; Soares W; Nicolaides KH
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):391-400. PubMed ID: 9674084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between nuchal translucency at 11-14 weeks and nuchal fold at 20-24 weeks of gestation.
    Salomon LJ; Bernard JP; Taupin P; Benard C; Ville Y
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):636-7. PubMed ID: 11844204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency.
    Zosmer N; Souter VL; Chan CS; Huggon IC; Nicolaides KH
    Br J Obstet Gynaecol; 1999 Aug; 106(8):829-33. PubMed ID: 10453834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal relationship between increased nuchal translucency and enlarged jugular lymphatic sac.
    Bekker MN; Twisk JW; Bartelings MM; Gittenberger-de Groot AC; van Vugt JM
    Obstet Gynecol; 2006 Oct; 108(4):846-53. PubMed ID: 17012445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.